Insulet Corp. (PODD)
NGS · Common · CUSIP 45784P101
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PODD and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
45784P101
Market Cap
Large Cap
Business: Insulet Corporation is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through their OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and a fully-automated cannula insertion. Insulet's Delivery Systems business also partners with global pharmaceutical and biotechnology companies to tailor the OmniPod technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas. Insulet's subsidiary, Neighborhood Diabetes, is a leading distributor of diabetes products and supplies, delivered through a high touch customer service model.

Company Contact

CEO
Jim Hollingshead
CFO
Ana Maria Chadwick
Headquarters
100 Nagog Park, Acton, MA 01720
Phone
978-600-7000 · Toll-Free 800-591-3455
Fax
978-600-0120
Investor Relations
Deborah R. Gordon · 978-600-7717 · dgordon@insulet.com
General Email
ir@insulet.com
SEC EDGAR Filings
View filings »